Completed
A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers
NCT01545570
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Minneapolis, Minnesota, United States